PRTN3 and rheumatoid arthritis: Recent genome-wide association studies have shown that significant risk allele frequencies were different between ACPA-positive and ACPA-negative RA patients, which showed a difference in distinct genetic etiologies of those two RA subsets, and provided further support for the need to consider them separately.